New: NCI-funded clinical trial search
Mednet Logo
CommunityPrimary Care

Do you still consider the use of pegloticase in someone with substantial tophaceous burden despite optimal uric acid levels?

For example, patient with sUA <4 already on maximum dose allopurinol or Uloric, but significant tophi that have only marginally reduced in size.
1 Answer
Mednet Member
Mednet MemberInvited Expert
Rheumatology · National institues of Health
Answered on · Updated on

If a patient has a significant burden of tophaceous deposits causing functional impairment despite serum uric acid control achieved through oral uric acid lowering therapy (ULT), I strongly recommend considering a course of enzymatic therapy with pegloticase. Terms such as “treatment failure gout” o...

Join for free or sign in to see the full answer